Atul Limited

Atul Limited

5,999.50
INR
-23.00
(-0.38%)
258.49EPS
25.58P/E
190.33BMarket Cap
Oct 23Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
808.86
880.31
857.1
936.53
1,111.12
1,337.24
1,351.83
1,240.63
1,698.12
1,817.9
1,583.01
1,871.5
2,106.91
2,231.49
Basic EPS, GAAP
73.9
81.13
92.44
108.88
93.21
145.72
224.69
221.17
204.23
174.15
109.54
164.37
230.25
252.7
Free Cash Flow per Basic Share
12.29
40.85
9.78
59.01
71.7
65.82
171.06
133.37
-121.49
-56.91
55.47
113.09
287.99
- -
Dividend per Share
7.02
8.79
10.29
12.04
12.85
13.9
51.09
- -
19.93
32.56
25.02
20
25
- -
Book Value per Share
319.81
471.75
544.4
662.79
756.5
912.19
1,063.63
1,295.26
1,496.93
1,582.78
1,737.1
1,901.57
2,113.31
- -
Tangible Book Value per Share
319.69
471.67
544.36
654.77
748.49
894.68
1,048.51
1,281.05
1,484.31
1,571.68
1,726.62
1,891.13
2,102.92
- -
Basic Weighted Avg Shares
30
30
30
30
30
30
30
30
30
30
29
29
29
29
Sales/Revenue/Turnover
23,992
26,112
25,423
27,779
32,958
39,665
40,098
36,784
50,242
53,664
46,680
55,100
62,031
65,696
Operating Margin (%)
13.11
12.84
15.7
15.25
11.98
16.44
19.42
21.28
14.69
11.45
8.53
10.93
11.54
12.75
Depreciation Expense
583
603
661
954
1,104
1,189
1,302
1,363
1,767
1,978
2,429
3,168
3,221
3,191
Net Income, GAAP
2,192
2,407
2,742
3,230
2,765
4,322
6,665
6,558
6,043
5,141
3,230
4,839
6,779
7,440
Effective Tax Rate (%)
28.55
30.39
32.19
27.51
31.77
35.91
20.64
25.14
25.32
26.34
28.07
27.97
23.44
25.1
Profit Margin (%)
9.14
9.22
10.78
11.63
8.39
10.9
16.62
17.83
12.03
9.58
6.92
8.78
10.93
11.32
Working Capital
3,600
4,193
3,525
5,395
7,868
10,850
13,500
17,579
16,904
12,507
13,872
20,611
29,336
- -
LT Debt
1,195
575
234
4
- -
431
933
1,045
668
340
2,140
1,861
1,636
- -
Total Equity
9,545
14,018
16,172
19,812
22,639
27,295
31,813
38,572
44,598
47,194
51,634
56,624
62,965
- -
Return on Invested Capital (%)
18.28
15.43
14.79
15.11
12.15
16.47
20.27
16.1
12.97
9.78
5.62
8.13
8.94
- -
Return on Capital (%)
19.74
17.03
15.99
16.64
12.65
17.1
22
18.06
14.19
11.25
6.48
8.63
11
- -
Return on Common Equity (%)
25.74
20.5
18.19
18.04
13.13
17.47
22.74
18.79
14.64
11.3
6.6
9.03
11.47
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
195
- -
LT Borrowings
- -
1,603
- -
LT Finance Leases
- -
33
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
29
29
29
Market Capitalization
180,802
187,500
190,326

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
40,556
- -
Cash, Cash Equivalents & STI
- -
17,399
- -
Accounts Receivable, Net
- -
12,710
- -
Inventories
- -
8,585
- -
Total Current Liabilities
- -
11,221
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
195
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.69%
10.34%
11.2%
Free Cash Flow
47.09%
-36.67%
154.66%
Net Income, GAAP
14.23%
5.99%
40.08%
Sales/Revenue/Turnover
10.21%
12.2%
12.58%
Total Cash Common Dividend
- -
- -
25%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
13,221
13,928
14,168
14,516
55,100
2026
14,780
- -
15,736
16,700
62,031
2027
18,480
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
38
46.47
36.93
42.97
164.37
2026
43.4
- -
54.6
71.38
230.25
2027
83.32
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
20
2026
- -
- -
- -
- -
25
2027
- -
- -
- -
- -
- -

Company Description

CEO
Sunil Siddharth Lalbhai
Full Time Employees
6,323
Sector
Process industries
Industry
Chemicals: agricultural
Address
Atul Valsad GU India 396020
IPO Date
Nov 15, 1994
Website
atul.co.in
Business
Atul Ltd, founded in 1947 and headquartered in Atul, Gujarat, India, manufactures and markets a broad portfolio of specialty chemicals, operating as one of India's largest integrated chemical companies with production facilities in Gujarat and Maharashtra, as well as subsidiaries in the United States, United Kingdom, United Arab Emirates, China, and Brazil; it serves over 4,000 customers across more than 30 industries in 90 countries. The company produces over 900 products and 400 formulations, organized into two main segments—Life Science Chemicals and Performance and Other Chemicals—encompassing organic intermediates such as para-cresol and para-anisic aldehyde; polymers and resins including epoxy phenol novolac and resorcinol formaldehyde; dyes and pigments like Vat Green 1, Pigment Red 168, and sulphur black; agrochemicals comprising 2,4-D, indoxacarb, and propoxur; and pharmaceutical active pharmaceutical ingredients such as acyclovir, fluconazole, and valacyclovir. Recent developments include the formation of a 50:50 joint venture with Buckman Laboratories (Asia) Pte. Ltd. in August 2025 named Atul-Buckman to manufacture and market advanced water treatment solutions in India and Sri Lanka; the commissioning of a 1,035 crore caustic-chlorine plant at its Atul facility in January 2024; the expansion of liquid epoxy resin capacity to 80,000 tons per annum completed in October 2024; the launch of a new patented post-emergence herbicide in 2024; and the inauguration of a 200-bed NABH-compliant multi-specialty hospital by Atul Healthcare in Pardi, Gujarat, in February 2025.